Financials data is unavailable for this security.
View more
Year on year Inno-Gene SA 's revenues fell -93.14% from 16.44m to 1.13m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 315.00k to a loss of 6.20m.
Gross margin | -44.16% |
---|---|
Net profit margin | -1,325.33% |
Operating margin | -565.58% |
Return on assets | -82.83% |
---|---|
Return on equity | -120.00% |
Return on investment | -115.27% |
More ▼
Cash flow in PLNView more
In 2023, Inno-Gene SA increased its cash reserves by 83.66%, or 128.00k. Cash Flow from Investing totalled 1.76m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 2.74m for operations while cash generated from financing totalled 855.00k.
Cash flow per share | -1.00 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4535 |
---|---|
Tangible book value per share | 0.4523 |
More ▼
Balance sheet in PLNView more
Current ratio | 1.20 |
---|---|
Quick ratio | 1.20 |
Total debt/total equity | 0.0107 |
---|---|
Total debt/total capital | 0.0106 |
More ▼